Boyd Peter E. 4

What Happened
Peter E. Boyd, Chief People Officer of Aquestive Therapeutics (AQST), had 56,778 shares withheld by the issuer on May 5, 2026 to satisfy tax withholding related to the vesting of Performance Stock Units (PSUs). The shares were valued at $4.18 each for a total of $237,332. This was a tax-withholding disposition rather than an open-market sale or new purchase.

Key Details

• Transaction date: 2026-05-05; Filing date: 2026-05-07. The report appears timely.
• Price per share: $4.18; Shares withheld/disposed: 56,778; Total value: $237,332.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: F1 — shares were withheld by the issuer to satisfy the reporting person’s tax withholding obligation on vested PSUs.
• Transaction type: F (tax withholding on vesting), not a purchase (P) or voluntary sale (S).

Context
This is a routine corporate action common when restricted or performance-based awards vest: the company withholds a portion of the vested shares to cover taxes rather than the executive selling shares on the open market. Such withholdings are administrative and do not necessarily indicate the insider’s view of the company’s stock.